Changing Diabetes® is Novo Nordisk’s response to the global diabetes challenge. Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. Our key contribution is to discover, develop and manufacture better biological medicines and make them accessible to people with diabetes throughout the world. However, it takes more than medicine to defeat diabetes.
By partnering with patients, policymakers, healthcare professionals and non-governmental organizations we are addressing diabetes risk factors in urban areas, ensuring that people with diabetes are diagnosed earlier and that they have access to adequate care to be able to live their lives with as few limitations as possible.